Current trends in research, development and production of prophylactic vaccines: Report of Vaccipharma 2015 Congress

R Acevedo, M Landys, D García-Rivera, S Fernandez, N Alvarez, VA Ferro, S Pagliusi, J Holst

Research output: Contribution to journalReview article

Abstract

On June 14-19, 2015, the IUPHAR Section of Immunopharmacology and the Cuban Society of Pharmacology, together with the Latin- American Association of Pharmacology (ALF), Finlay Vaccine Institute and other prestigious Cuban scientific institutions, organized the Congress VACCIPHARMA 2015 (3rd International Congress on Pharmacology of Vaccines), held as part of the First International Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2015 (Meliá Marina Varadero Hotel, in Varadero beach, Cuba) VACCIPHARMA 2015 was organised into two large Workshops, addressing topics related to the research, development, clinical evaluation, production and quality control of Therapeutic and Prophylactic Vaccines, respectively. At the same time the Workshop on Prophylactic Vaccines was integrated by several Symposiums, focused on meningococcal, pneumococcal, enteric, tuberculosis and pertussis vaccines. About 250 delegates, including 100 international researchers from 15 countries, attended this meeting. The Congress had a remarkable Opening Session, with a Key Lecture given by the outstanding scientist Professor Dr. Shiv Pillai (United States of America), who talked about the changing views in the field of the immunology of vaccination and the challenges ahead. The aim of this review is to give an overview of the main topics discussed in the Prophylactic Vaccines Workshop, not as a complete narration of the events, but to provide an update of the latest state of the art and methodologies being applied to prophylactic vaccines with an expert commentary on the invited speakers.
LanguageEnglish
Article number00151
Number of pages13
JournalSOJ Immunology
Volume4
Issue number2
DOIs
Publication statusPublished - 25 Oct 2016

Fingerprint

Vaccines
Research
Pharmacology
Education
Melia
Narration
Tuberculosis Vaccines
Pertussis Vaccine
Cuba
Pneumococcal Vaccines
Allergy and Immunology
Quality Control
Vaccination
Research Personnel
Therapeutics

Keywords

  • vaccine
  • Neisseria meningitidi
  • Mycobacterium tuberculosis
  • combined vaccines
  • enteric vaccines
  • pneumococcal vaccines
  • Bordetella pertussis
  • Salmonella Typhi
  • prophylactic vaccines

Cite this

Acevedo, R ; Landys, M ; García-Rivera, D ; Fernandez, S ; Alvarez, N ; Ferro, VA ; Pagliusi, S ; Holst, J. / Current trends in research, development and production of prophylactic vaccines : Report of Vaccipharma 2015 Congress. In: SOJ Immunology. 2016 ; Vol. 4, No. 2.
@article{1e34c85ce40b4f7587128731713a3676,
title = "Current trends in research, development and production of prophylactic vaccines: Report of Vaccipharma 2015 Congress",
abstract = "On June 14-19, 2015, the IUPHAR Section of Immunopharmacology and the Cuban Society of Pharmacology, together with the Latin- American Association of Pharmacology (ALF), Finlay Vaccine Institute and other prestigious Cuban scientific institutions, organized the Congress VACCIPHARMA 2015 (3rd International Congress on Pharmacology of Vaccines), held as part of the First International Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2015 (Meli{\'a} Marina Varadero Hotel, in Varadero beach, Cuba) VACCIPHARMA 2015 was organised into two large Workshops, addressing topics related to the research, development, clinical evaluation, production and quality control of Therapeutic and Prophylactic Vaccines, respectively. At the same time the Workshop on Prophylactic Vaccines was integrated by several Symposiums, focused on meningococcal, pneumococcal, enteric, tuberculosis and pertussis vaccines. About 250 delegates, including 100 international researchers from 15 countries, attended this meeting. The Congress had a remarkable Opening Session, with a Key Lecture given by the outstanding scientist Professor Dr. Shiv Pillai (United States of America), who talked about the changing views in the field of the immunology of vaccination and the challenges ahead. The aim of this review is to give an overview of the main topics discussed in the Prophylactic Vaccines Workshop, not as a complete narration of the events, but to provide an update of the latest state of the art and methodologies being applied to prophylactic vaccines with an expert commentary on the invited speakers.",
keywords = "vaccine, Neisseria meningitidi, Mycobacterium tuberculosis, combined vaccines, enteric vaccines, pneumococcal vaccines, Bordetella pertussis, Salmonella Typhi, prophylactic vaccines",
author = "R Acevedo and M Landys and D Garc{\'i}a-Rivera and S Fernandez and N Alvarez and VA Ferro and S Pagliusi and J Holst",
year = "2016",
month = "10",
day = "25",
doi = "10.15226/2372-0948/4/2/00152",
language = "English",
volume = "4",
journal = "SOJ Immunology",
issn = "2372-0948",
number = "2",

}

Acevedo, R, Landys, M, García-Rivera, D, Fernandez, S, Alvarez, N, Ferro, VA, Pagliusi, S & Holst, J 2016, 'Current trends in research, development and production of prophylactic vaccines: Report of Vaccipharma 2015 Congress' SOJ Immunology, vol. 4, no. 2, 00151. https://doi.org/10.15226/2372-0948/4/2/00152

Current trends in research, development and production of prophylactic vaccines : Report of Vaccipharma 2015 Congress. / Acevedo, R; Landys, M; García-Rivera, D; Fernandez, S; Alvarez, N; Ferro, VA; Pagliusi, S; Holst, J.

In: SOJ Immunology, Vol. 4, No. 2, 00151, 25.10.2016.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Current trends in research, development and production of prophylactic vaccines

T2 - SOJ Immunology

AU - Acevedo, R

AU - Landys, M

AU - García-Rivera, D

AU - Fernandez, S

AU - Alvarez, N

AU - Ferro, VA

AU - Pagliusi, S

AU - Holst, J

PY - 2016/10/25

Y1 - 2016/10/25

N2 - On June 14-19, 2015, the IUPHAR Section of Immunopharmacology and the Cuban Society of Pharmacology, together with the Latin- American Association of Pharmacology (ALF), Finlay Vaccine Institute and other prestigious Cuban scientific institutions, organized the Congress VACCIPHARMA 2015 (3rd International Congress on Pharmacology of Vaccines), held as part of the First International Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2015 (Meliá Marina Varadero Hotel, in Varadero beach, Cuba) VACCIPHARMA 2015 was organised into two large Workshops, addressing topics related to the research, development, clinical evaluation, production and quality control of Therapeutic and Prophylactic Vaccines, respectively. At the same time the Workshop on Prophylactic Vaccines was integrated by several Symposiums, focused on meningococcal, pneumococcal, enteric, tuberculosis and pertussis vaccines. About 250 delegates, including 100 international researchers from 15 countries, attended this meeting. The Congress had a remarkable Opening Session, with a Key Lecture given by the outstanding scientist Professor Dr. Shiv Pillai (United States of America), who talked about the changing views in the field of the immunology of vaccination and the challenges ahead. The aim of this review is to give an overview of the main topics discussed in the Prophylactic Vaccines Workshop, not as a complete narration of the events, but to provide an update of the latest state of the art and methodologies being applied to prophylactic vaccines with an expert commentary on the invited speakers.

AB - On June 14-19, 2015, the IUPHAR Section of Immunopharmacology and the Cuban Society of Pharmacology, together with the Latin- American Association of Pharmacology (ALF), Finlay Vaccine Institute and other prestigious Cuban scientific institutions, organized the Congress VACCIPHARMA 2015 (3rd International Congress on Pharmacology of Vaccines), held as part of the First International Convention IMMUNOPHARMACOLOGY–VACCIPHARMA 2015 (Meliá Marina Varadero Hotel, in Varadero beach, Cuba) VACCIPHARMA 2015 was organised into two large Workshops, addressing topics related to the research, development, clinical evaluation, production and quality control of Therapeutic and Prophylactic Vaccines, respectively. At the same time the Workshop on Prophylactic Vaccines was integrated by several Symposiums, focused on meningococcal, pneumococcal, enteric, tuberculosis and pertussis vaccines. About 250 delegates, including 100 international researchers from 15 countries, attended this meeting. The Congress had a remarkable Opening Session, with a Key Lecture given by the outstanding scientist Professor Dr. Shiv Pillai (United States of America), who talked about the changing views in the field of the immunology of vaccination and the challenges ahead. The aim of this review is to give an overview of the main topics discussed in the Prophylactic Vaccines Workshop, not as a complete narration of the events, but to provide an update of the latest state of the art and methodologies being applied to prophylactic vaccines with an expert commentary on the invited speakers.

KW - vaccine

KW - Neisseria meningitidi

KW - Mycobacterium tuberculosis

KW - combined vaccines

KW - enteric vaccines

KW - pneumococcal vaccines

KW - Bordetella pertussis

KW - Salmonella Typhi

KW - prophylactic vaccines

U2 - 10.15226/2372-0948/4/2/00152

DO - 10.15226/2372-0948/4/2/00152

M3 - Review article

VL - 4

JO - SOJ Immunology

JF - SOJ Immunology

SN - 2372-0948

IS - 2

M1 - 00151

ER -